Kynurenine pathway metabolism in the galactosamine model of hepatic injury

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 421-424

  Saito, K ^a   Seishima, M ^a   Noma, A ^a   Nagamura, Y ^b   Quearry, B J ^c   Markey, S P ^c   Heyes, M P ^c  

^a GIFU UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSAMINE; KYNURENINE; LIPOPOLYSACCHARIDE; QUINOLINIC ACID; TRYPTOPHAN 2,3 DIOXYGENASE;

ANIMAL; ARTICLE; BRAIN; DRUG EFFECT; FEMALE; GERBIL; HEPATIC ENCEPHALOPATHY; LIVER; LUNG; METABOLISM; PATHOLOGY; SALMONELLA;

ANIMALS; BRAIN; FEMALE; GALACTOSAMINE; GERBILLINAE; HEPATIC ENCEPHALOPATHY; KYNURENINE; LIPOPOLYSACCHARIDES; LIVER; LUNG; QUINOLINIC ACID; SALMONELLA; TRYPTOPHAN OXYGENASE;

EID: 0030341956     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_65     Document Type: Article

References (10)

1. Bender, D.A. and McCreanor, 1985, Kynurenine hydroxylase: a potential rate-limiting enzyme in tryptophan metabolism Biochem Soc Trans 13: 441.
2. Eastman C.L. and Guilarte T.R., 1989, Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line. Brain Research 495: 225.
3. Foster A.C., Vezzani A., French E.D. and Schwarcz R., 1984, Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci. Lett. 48: 273.
4. Heyes, M.P., Saito, K., Crowley, J., Davis, L.E., Demitrak, M.A. et al.. 1992, Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurologic disease Brain 115: 1249.
5. James J.H., Hodgman J.M. Funovics J.M. Yoshimura N., and Fischer J.E., 1976, Brain tryptophan, plasma free tryptophan and distribution of plasma neutral amino acids. Metabolism 25: 471.
6. Lapin I.P., 1982, Convulsant action of intracerebroventricularly administered L-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships. Neuropharmacology 21: 1227.
7. Saito, K., Markey, S.P. and Heyes, M.P., 1991, Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice Brain Research 546: 151.
8. Saito, K., Markey, S.P. and Heyes, M.P., 1992, Effects of immune activation on quinolinic acid and kynurenine pathway metabolism in the mouse Neuroscience 51: 25.
9. Schwarcz, R., Whetsell, W.O. and Mangano, R.E.M., 1983, Quinolinic acid: an endogenous metabolite can produce axon sparing lesions in rat brain Science 219: 316.
10. Whetsell W.O. and Schwarcz R., 1989, Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci. Lett. 97: 271.